Exclusive

Publication

Byline

Location

Posco Dx Slips To Loss In Q4 On Weak Sales

India, Jan. 28 -- Posco Dx Company Ltd. (022100.KS), a South Korean logistics solution provider, reported Wednesday a loss in its fourth quarter, compared to prior year's profit, amid weak sales. In ... Read More


Tele2 Q4 Earnings Rise On Service Revenue Growth

India, Jan. 28 -- Tele2 AB (TEL2-B.ST), a Nordic and Baltic telecom operator, on Wednesday reported increased earnings in the fourth quarter, supported by organic growth in service revenue across all ... Read More


KPN Full-year Net Profit Edges Up, Announces 250 Mln Share Buyback In 2026

India, Jan. 28 -- Koninklijke KPN NV (KPN), a telecommunications and IT service provider, on Wednesday reported net profit of 855 million for the full year, 0.9% up from 847 million a year ago. The c... Read More


Oracle Says Data Center Outage Caused Issues Faced By US TikTok Users

India, Jan. 28 -- Tech major Oracle Corp. (ORCL), which offers cloud infrastructure to TikTok, reportedly said that a temporary weather-related power outage at an Oracle data center caused the issues ... Read More


ASML Q4 Earnings Rise; Sees FY26 Sales Growth; Raises Dividend; Launches EUR 12 Bln Buyback

India, Jan. 28 -- ASML Holding N.V. (ASML,ASML.AS), on Wednesday reported higher fourth-quarter net income, while providing net sales guidance for 2026, announcing a higher dividend for 2025, and unve... Read More


ST Engineering's 2025 Contract Wins Rise 49% To S$18.7 Bln

India, Jan. 28 -- Singapore Technologies Engineering Ltd (S63.SI) said on Wednesday it secured about S$4.7 billion of new contracts in the fourth quarter of 2025, lifting total contract wins for the y... Read More


J&J Secures FDA Approval For DARZALEX FASPRO Combo In Newly Diagnosed Multiple Myeloma

India, Jan. 28 -- Drug major Johnson & Johnson (JNJ) announced Tuesday that DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) -based quadruplet regimen has received the U.S. Food and Drug Administr... Read More


Altimmune Prices $75 Mln Of Share Offering; Stock Down

India, Jan. 28 -- Altimmune, Inc. (ALT), a late clinical-stage biopharmaceutical company, said it entered into an agreement with a new fundamental institutional investor for the purchase and sale of 1... Read More


European Shares Subdued As Uncertainties Galore

India, Jan. 26 -- European stocks were muted on Monday as Iran-U.S. tensions escalated and traders looked ahead to the U.S. Federal Reserve's policy decision later in the week for direction. U.S. Pre... Read More


Insource Co.,Ltd. Q1 Income Advances

India, Jan. 26 -- Insource Co.,Ltd. (6200.T) reported a profit for its first quarter that Increased, from last year The company's bottom line totaled JPY962.78 million, or JPY11.46 per share. This co... Read More